Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 18;113(12):1925-1946.e11.
doi: 10.1016/j.neuron.2025.03.034. Epub 2025 Apr 30.

CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density

Affiliations

CLU alleviates Alzheimer's disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density

Alexandra M Lish et al. Neuron. .

Abstract

Genetic studies implicate clusterin (CLU) in the pathogenesis of Alzheimer's disease (AD), yet its precise molecular impact remains unclear. Through unbiased proteomic profiling and functional validation in CLU-deficient astrocytes, we identify increased nuclear factor κB (NF-κB)-dependent signaling and complement C3 secretion. Reduction of astrocyte CLU induced microglia-dependent modulation of extracellular apolipoprotein E (APOE) and phosphorylated tau, as well as increased microglial phagocytosis and reduced synapse numbers. By integrating mouse and human cellular models with comprehensive analyses of human plasma and brain tissue, we demonstrate that CLU AD-risk alleles are associated with reduced CLU protein and heightened inflammatory profiles. These findings establish a mechanistic link between AD genetic risk factors, astrocyte reactivity, and microglia-mediated effects on synaptic integrity. Collectively, these results support a model in which CLU upregulation in response to neuropathology is associated with maintenance of cognitive function, while diminished astrocyte CLU levels heighten disease susceptibility.

Keywords: APOE; Alzheimer’s disease; TAU; astrocyte reactivity; astrocyte-microglia crosstalk; clusterin; complement; human iPSC cells; risk variants; synapse density.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Bertrand P, Poirier J, Oda T, Finch CE, and Pasinetti GM (1995). Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res. Mol. Brain Res 33, 174–178. 10.1016/0169-328x(95)00097-c. - DOI - PubMed
    1. Lidström AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, and Blennow K (1998). Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer’s disease. Exp. Neurol 154, 511–521. 10.1006/exnr.1998.6892. - DOI - PubMed
    1. May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, and Finch CE (1990). Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer’s disease and in response to experimental lesions in rat. Neuron 5, 831–839. 10.1016/0896-6273(90)90342-d. - DOI - PubMed
    1. Miners JS, Clarke P, and Love S (2017). Clusterin levels are increased in Alzheimer’s disease and influence the regional distribution of Aβ. Brain Pathol. 27, 305–313. 10.1111/bpa.12392. - DOI - PMC - PubMed
    1. Duguid JR, Bohmont CW, Liu NG, and Tourtellotte WW (1989). Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A 86, 7260–7264. 10.1073/pnas.86.18.7260. - DOI - PMC - PubMed

LinkOut - more resources